Charles River Labs Intl Stock
Charles River Labs Intl Stock
Charles River Labs Intl shows a slight decrease today, losing -€0.950 (-0.570%) compared to yesterday.
Charles River Labs Intl is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
With a current price of 164.45 € Charles River Labs Intl is right around the predicted target price of 165 €.
Pros and Cons of Charles River Labs Intl in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Charles River Labs Intl vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Charles River Labs Intl | -0.570% | 3.918% | 9.780% | -11.443% | -6.959% | -14.295% | -17.362% |
| Ironwood Pharmaceuticals | -2.550% | 4.795% | 19.531% | -8.383% | -27.143% | -73.167% | -68.934% |
| Novocure Ltd | -1.160% | 9.135% | 15.722% | -60.508% | -61.023% | -84.133% | -91.990% |
| Iovance Biotherapeutics Inc. | 0.650% | -0.393% | -14.490% | -75.357% | -72.809% | -71.362% | -95.447% |
Comments
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) had its price target lowered by analysts at TD Cowen from $205.00 to $197.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at Barclays PLC from $195.00 to $210.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CRL provided by MarketBeat
News
Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2025 financial results on Wednesday, August 6th, before the market opens. A conference call has been scheduled
Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a recycling program, developed in partnership with international recycling leader TerraCycle®, to give new life to